it is hard to see how AHZ will be profitable in any near time frame. It certainly won't be next financial year nor probably the one after that.... perhaps just too much patience required for this one.
I'll be waiting for any spike in the sp due to the (ridiculously) overdue Phase I trial results then pull out and sit on the sidelines - because after the vaccine results are announced what the hell is left to drive the price any higher for a long time to come?.....
News: Admedus revenue up 7.09% for FY2014, page-12
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |